Our ElectedEurope
← EU legislation

2021/2608(RPS)

The draft Commission regulation amending Annexes II, III and IV to Regulation (EC) No 396/2005 as regards maximum residue levels for acequinocyl, acibenzolar-S-methyl, Bacillus subtilis strain IAB/BS03, emamectin, flonicamid, flutolanil, fosetyl, imazamox and oxathiapiprolin in or on certain products

The draft Commission regulation amending Annexes II, III and IV to Regulation (EC) No 396/2005 as regards maximum residue levels for acequinocyl, acibenzolar-S-methyl, Bacillus subtilis strain IAB/BS03, emamectin, flonicamid, flutolanil, fosetyl, imazamox and oxathiapiprolin in or on certain products

At a glance

This is 2021/2608(RPS). Its recorded status is not supplied, and 1 linked roll-call vote appear in this research record.

Source and coverage

Source last checked
28/08/2026, 06:01:26
Record current through
24/08/2026
Institution
European Union / European Parliament
Parliamentary term
Depends on procedure timeline

Coverage limitations: Linked votes are only those for which the ingestion source supplies a reliable procedure relationship. Absence here is not proof that no related parliamentary activity occurred.

Read reporting and briefings ↗

Procedure
RPS
Status
In progress / not supplied

Linked roll-call votes

Amendments and procedural votes are shown alongside the main/final vote when recorded.

2021/2608(RPS): The draft Commission regulation amending Annexes II, III and IV to Regulation (EC) No 396/2005 as regards maximum residue levels for acequinocyl, acibenzolar-S-methyl, Bacillus subtilis strain IAB/BS03, emamectin, flonicamid, flutolanil, fosetyl, imazamox and oxathiapiprolin in or on certain products — EU legislation tracker · Our Elected Europe